Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

NCT04005170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Esophageal Cancer

Interventions

DRUG: Toripalimab
DRUG: Paclitaxel/Cisplatin
RADIATION: Intensity-modulated radiotherapy

Sponsor

Mian XI